| Synthesis and anti-inflammatory activity of some novel pyrazole derivatives of gallic acid S Arunkumar, K Ilango, RS Manikandan, N Ramalakshmi Journal of Chemistry 6, S123-S128, 2009 | 47 | 2009 |
| Synthesis, In Vitro Antitubercular Activity and 3D‐QSAR of Novel Quinoxaline Derivatives A Puratchikody, R Natarajan, M Jayapal, M Doble Chemical biology & drug design 78 (6), 988-998, 2011 | 44 | 2011 |
| Synthesis and Biological Evaluation of Some Novel Nicotinic Acid Derivatives N Ramalakshmi, L Aruloly, S Arunkumar, K Ilango, A Puratchikody Malaysian journal of science 28 (2), 197-203, 2009 | 21 | 2009 |
| Toxicity risk assesment of isatins CN Nalini, SR Deepthi, N Ramalakshmi, G Uma Rasayan Journal of chemistry 4 (4), 829-833, 2011 | 20 | 2011 |
| Synthesis, characterisation and biological evaluation of some novel 2, 5-disubstituted-1, 3, 4-oxadiazole derivatives of gallic acid S Arunkumar, K Ilango, RS Manikandan, M Sudha, N Ramalakshmi Int. J. ChemTech Res 1 (4), 1094-1099, 2009 | 20 | 2009 |
| Synthesis and biological evaluation of 4-aryl-3-chloro-1-nicotinamido-2-azetidinones as potential anticonvulsant and antimycobacterial agents N Ramalakshmi, R Vijayakumar, K Ilango, S Arunkumar, A Puratchikody Int. J. Chem. Sci 6 (3), 1213-1222, 2008 | 16 | 2008 |
| Structure-Activity Relationships of Pyrimidine Derivatives and Their Biological Activity - A Review HNASAS Ramalakshmi Natarajan Medicinal Chemistry, 2022 | 15* | 2022 |
| Synthesis and biological evaluation of some novel triazolo, thiadiazole derivatives of gallic acid. S Arunkumar, K Ilango, B Ravindar, N Ramalakshmi Der Pharma Chemica 1 (1), 70-77, 2009 | 15 | 2009 |
| Multitarget Directed Ligand Approaches for Alzheimer’s Disease: A Complete Review NCN Ramalakshmi.N, Remya RS Mini reviews in medicinal chemistry 21 (16), 2361 - 2388, 2021 | 14* | 2021 |
| Toxicity risk assessment of some novel quinoxaline fused thiazolidinones A Puratchikody, M Doble, N Ramalakshmi J Pharm Res 5, 340, 2012 | 14 | 2012 |
| SYNTHESIS, CHARACTERISATION AND BIOLOGICAL EVALUATION OF NOVEL COUMARIN DERIVATIVES SAKAU P. Selvam*1, N. Ramlakshmi1, G. Uma1 Rasayan J chem 3 (2), 275-280, 2010 | 13 | 2010 |
| Synthesis and pharmacological evaluation of some derivatives of gallic acid S Arunkumar, N Ramalakshmi, T Saraswathy, L Aruloly Indian Journal of heterocyclic chemistry 16 (1), 29, 2006 | 13 | 2006 |
| QSAR and Molecular Docking Studies of Pyrimidine–Coumarin–Triazole Conjugates as Prospective Anti-Breast Cancer Agents ABS Arun Kumar Subramani ,Amuthalakshmi Sivaperuman ,Ramalakshmi Natarajan ... molecules 27 (6), 1845, 2022 | 11 | 2022 |
| 2DQuantitative Structure Activity Relationship (QSAR) Modeling, docking studies, synthesis and in-vitro evaluation on 1,3,4-thiadiazole tethered coumarin derivatives as … N. Ramalakshmi, P. Manimegalai, R.R. Bhandare, S. Arunkumar, A.B. Shaik Journal of Saudi Chemical Society 25 (7), 101279, 2021 | 9 | 2021 |
| A new era in medicine–neutraceuticals G Sreeramya, CN Nalini, N Ramalakshmi, K Sahini, SA Lakshmi Research Journal of Pharmacy and Technology 11 (8), 3572-3576, 2018 | 9 | 2018 |
| Synthesis, characterization and biological screening of some novel 1, 3, 5 trisubstituted 2-pyrazolines N Ramalakshmi, S Deepa, KS Srinivas, A Puratchikody, S Arunkumar Rasayan Journal of Chemistry 2 (2), 393-396, 2009 | 8 | 2009 |
| A Comprehensive Review on DNA Gyrase Inhibitors PM S. R. Chitra, N. Ramalakshmi, S. Arun Kumar Infectious Disorders - Drug Targets 26, 765-777, 2020 | 7* | 2020 |
| Impurity profiling an emerging trend in Pharmaceuticals: A Review A Chanda, N Ramalakshmi, C Nalini, S Mahabubi PharmaTutor 3 (11), 29-35, 2015 | 7 | 2015 |
| Synthesis, characterisation and pharmacological evaluation of novel 4-aryl 3-chloro n-pyridine 2-yl 2- azetidinone RVB Natarajan Ramalakshmishmi, Selvaraj Deepa Antro jenny, Gopi, Subramani ... International Journal of ChemTech Research 1 (4), 1000-1004, 2009 | 7* | 2009 |
| Biological evaluation of some novel quinoxaline bearing azetidinones including leptospirocidal study DS Ramalakshmi Natarajan, Arunkumar Subramani, Sathesh Kumar Kesavan JPR:BioMedRx 1 (8), 775-778, 2013 | 6* | 2013 |
